Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. Abstract Text:

    fredrik lindmarkFredrik Lindmark,s lilly zhengS Lilly Zheng,fredrik wiklundFredrik Wiklund,jeannette bensenJeannette Bensen,katarina augustsson Katarina Augustsson ,baoli changBaoli Chang,maria hedelinMaria Hedelin,jonathan clarkJonathan Clark, stattin Stattin,deborah a meyersDeborah A Meyers,hans-olov adamiHans-Olov Adami,william isaacsWilliam Isaacs,henrik Henrik ,jianfeng xuJianfeng Xu,

    BACKGROUND: Accumulating epidemiologic and molecular evidence suggest that inflammation is an important component in the etiology of prostate cancer. Macrophage-inhibitory cytokine-1 (MIC-1), a member of the transforming growth factor beta superfamily, is thought to play an important role in inflammation by regulating macrophage activity. We examined whether sequence variants in the MIC-1 gene are associated with the risk of prostate cancer. METHODS: The study population, a population-based case-control study in Sweden, consisted of 1383 prostate cancer case patients and 780 control subjects. From 94 of the control subjects, we constructed gene-specific haplotypes of MIC-1 and identified four haplotype-tagging single-nucleotide polymorphisms (SNPs): Exon1+25 (V9L), Exon1+142 (S48T), IVS1+1809, and Exon2+2423 (H6D). All study subjects were genotyped for the four SNPs, and conditional logistic regression analysis was used to estimate odds ratios (ORs) with 95% confidence intervals (CIs). RESULTS: A statistically significant difference (P =.006) in genotype frequency was observed for the nonsynonymous change H6D (histidine to aspartic acid at position 6) between prostate cancer patients and control subjects. Carriers of the GC genotype, which results in the H6D change, experienced a lower risk of sporadic prostate cancer (OR = 0.80, 95% CI = 0.66 to 0.97) and of familial prostate cancer (OR = 0.61, 95% CI = 0.42 to 0.89) than the CC genotype carriers. In the study population, the proportion of prostate cancer cases attributable to the CC genotype was 7.2% for sporadic cancer and 19.2% for familial cancer. None of the other SNPs or haplotypes was associated with prostate cancer. CONCLUSION: This study shows an association between a nonsynonymous change (H6D) in the MIC-1 gene and prostate cancer. This finding supports the hypothesis that genetic variation in the inflammatory process contributes to prostate cancer susceptibility.

    H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. Publishing Authors By Initials

    f lindmarkF Lindmark,sl zhengSL Zheng,f wiklundF Wiklund,j bensenJ Bensen,ka KA ,b changB Chang,m hedelinM Hedelin,j clarkJ Clark,p stattinP Stattin,da meyersDA Meyers,ho adamiHO Adami,w isaacsW Isaacs,h H ,j xuJ Xu,

    For similar geographic locations: europe: scandinavia: sweden research abstracts see: geographic locations: europe: scandinavia: sweden research

    PUBMED ID PMID:

    MEDLINE DATE:

    H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of the National Cancer Institute

    VOLUME: 96

    Page Numbers: 1248-54

    Journal Abbreviation: J. Natl. Cancer Inst.

    ISSN: 1460-2105

    DAY: 18

    MONTH: Aug

    YEAR: 2004

    H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7503089

    H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. Keywords Mesh Terms:

    KEYWORDS: Sweden

    MESH TERMS: genetics

    Chemical & Substance for Abstract: H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. Information

    Substance Name: growth differentiation factor 15

    Registry Number: 0

    Grant and Affiliation Information for H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.

    AFFILIATION: Department of Radiation Sciences/Oncology, Umeå University, Umeå, Sweden.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Natl Cancer Inst

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News